Cyclosporin-A inhibits the expression of cyclooxygenase-2 in gingiva

Journal of Periodontal Research

Volumn 42, Issue 5, 2007, Pages 443-449

  Chiang, C Y ^b   Chen, Y T ^b   Hung, F M ^a,b   Tu, H P ^b,c   Fu, M M J ^a,b   Fu, E ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Adverse effects; Cyclooxygenase; Cyclosporin; Gingiva

Indexed keywords

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; ENZYME INHIBITOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL; ARTICLE; CELL CULTURE; DRUG EFFECT; EDENTULOUSNESS; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; FIBROBLAST; GINGIVA; HUMAN; PATHOLOGY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; STROMA CELL; WESTERN BLOTTING;

ADULT; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOSPORINE; DINOPROSTONE; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GINGIVA; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; JAW, EDENTULOUS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548291903     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2006.00967.x     Document Type: Article

References (37)

1. Deliliers GL, Santoro F, Polli N, Bruno E, Fumagalli L, Risciotti E. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986 57 : 771 775.
2. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: a side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983 55 : 274 278.
3. Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983 10 : 237 246.
4. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992 63 : 548 553.
5. Fu E, Nieh S, Wikesjo UM. The effect of plaque retention on cyclosporine-induced gingival overgrowth in rats. J Periodontol 1997 68 : 92 98.
6. Pilatti GL, Sampaio JE. The influence of chlorhexidine on the severity of cyclosporin A-induced gingival overgrowth. J Periodontol 1997 68 : 900 904.
7. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991 18 : 107 110.
8. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 1993 28 : 500 510.
9. Iacopino AM, Doxey D, Cutler CW et al. Phenytoin and cyclosporine A specifically regulate macrophage phenotype and expression of platelet-derived growth factor and interleukin-1 in vitro and in vivo: possible molecular mechanism of drug-induced gingival hyperplasia. J Periodontol 1997 68 : 73 83.
10. Chen YT, Tu HP, Chin YT et al. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor gene and protein expression in cyclosporin-induced overgrown edentulous gingiva in rats. J Periodontol 2005 76 : 2267 2275.
11. Morton RS, Dongari-Bagtzoglou AI. Regulation of gingival fibroblast interleukin-6 secretion by cyclosporine A. J Periodontol 1999 70 : 1464 1471.
12. Myrillas TT, Linden GJ, Marley JJ, Irwin CR. Cyclosporin A regulates interleukin-1beta and interleukin-6 expression in gingiva: implications for gingival overgrowth. J Periodontol 1999 70 : 294 300.
13. Williamson MS, Miller EK, Plemons J, Rees T, Iacopino AM. Cyclosporine A upregulates interleukin-6 gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994 65 : 895 903.
14. Morton RS, Dongari-Bagtzoglou AI. Cyclooxygenase-2 is upregulated in inflamed gingival tissues. J Periodontol 2001 72 : 461 469.
15. Fu E, Hsieh YD, Shen EC, Nieh S, Mao TK, Chiang CY. Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: a morphological and histometric evaluation. J Periodontol 2001 72 : 889 894.
16. Chang CT, Hung CC, Yang CW, Vandewalle A, Wu MS. Cyclosporine decreases prostaglandin E2 production in mouse medullary thick ascending limb cultured cells. Transpl Int 2005 18 : 871 878.
17. Guhring H, Gorig M, Ates M et al. Suppressed injury-induced rise in spinal prostaglandin E2 production and reduced early thermal hyperalgesia in iNOS-deficient mice. J Neurosci 2000 20 : 6714 6720.
18. Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J Immunol 1999 163 : 374 379.
19. Melhus A. Effects of amoxicillin on the expression of cytokines during experimental acute otitis media caused by non-typeable Haemophilus influenzae. J Antimicrob Chemother 2001 48 : 397 402.
20. Sun J, Wang XD, Liu H, Xu JG. Ketamine suppresses intestinal NF-kappa B activation and proinflammatory cytokine in endotoxic rats. World J Gastroenterol 2004 10 : 1028 1031.
21. Drissi H, Lomri A, Lasmoles F, Holy X, Zerath E, Marie PJ. Skeletal unloading induces biphasic changes in insulin-like growth factor-I mRNA levels and osteoblast activity. Exp Cell Res 1999 251 : 275 284.
22. Yoshimura R, Sano H, Masuda C et al. Expression of cyclooxygenase-2 in prostate carcinoma. Cancer 2000 89 : 589 596.
23. Miura M, Gronthos S, Zhao M et al. SHED. stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003 100 : 5807 5812.
24. Tordjman C, Serkiz B, Rambaud F, Bonnet J, Volland JP. High-performance liquid chromatographic quantitation of cyclooxygenase and lipoxygenase metabolites of arachidonic acid from rat polymorphonuclear leukocytes. J Chromatogr 1990 532 : 135 143.
25. Attur MG, Patel R, Thakker G et al. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. Inflamm Res 2000 49 : 20 26.
26. Goppelt-Struebe M, Esslinger B, Kunzendorf U. Failure of cyclosporin A to induce transforming growth factor beta (TGF-beta) synthesis in activated peripheral blood lymphocytes. Clin Transplant 2003 17 : 20 25.
27. Miyauchi M, Hiraoka M, Oka H et al. Immuno-localization of COX-1 and COX-2 in the rat molar periodontal tissue after topical application of lipopolysaccharide. Arch Oral Biol 2004 49 : 739 746.
28. Wondimu B, Modeer T. Cyclosporin A upregulates prostaglandin E2 production in human gingival fibroblasts challenged with tumor necrosis factor alpha in vitro. J Oral Pathol Med 1997 26 : 11 16.
29. Hocherl K, Dreher F, Vitzthum H, Kohler J, Kurtz A. Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol 2002 13 : 2427 2436.
30. Hocherl K, Kees F, Kramer BK, Kurtz A. Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression. Kidney Int 2004 65 : 2071 2080.
31. Smit-van Oosten A, Boonstra AH, Navis G, van Goor H, Buikema H. Reduced cyclooxygenase involvement in vascular endothelial function in rat renal transplantation. Nephron Physiol 2005 100 : 21 30.
32. Her nandez GL, Volpert OV, Iniguez MA et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A. roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med 2001 193 : 607 620.
33. Rafiee P, Heidemann J, Ogawa H et al. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal 2004 2 : 3.
34. Sugimoto T, Haneda M, Sawano H et al. Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells. J Am Soc Nephrol 2001 12 : 1359 1368.
35. Chen T, Guo J, Yang M et al. Cyclosporin A impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression. Blood 2004 103 : 413 421.
36. Stamp LK, Cleland LG, James MJ. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. J Rheumatol 2004 31 : 1246 1254.
37. Tipton DA, Pabst MJ, Dabbous MK. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990 44 : 253 264.